Pulmonology

Your Article Summary

See Latest Articles

New drugs for exacerbations of chronic obstructive pulmonary disease
The Lancet, 08/31/09

Hansel TT et al. – COPD is also associated with corticosteroid resistance, abnormal macrophage and T–cell populations in the airway, autoinflammation and autoimmunity, aberrant fibrosis, accelerated ageing, systemic and concomitant disease, and defective regeneration. Such concepts have been used to generate a range of molecular targets, and clinical trials are taking place to identify effective drugs for the prevention and treatment of COPD exacerbations.

Today in COPD...keeping you current

Receive free subspecialty "5-minute updates" via email

Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09

Hemodynamic and Gas Exchange Effects of Sildenafil in Patients with COPD and Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine, 10/30/09

The ADMIT series - Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD
Primary Care Respiratory Journal, 11/05/09

See All of COPD

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09

Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 10/27/09

A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency Department
Archives of Pediatrics and Adolescent Medicine, 11/23/09

See All of Clinical Pharmacology